Back

Delayed dynamics of migratory response to CTLA-4 blockade reveals a mechanistic view on potential T cells reinvigoration following immune checkpoint blockade

Safaeifard, F.; Shariatpanahi, S. P.; Golieai, B.; Aref, A. R.; Foroughmand-Araabi, M.-H.; Goliaei, S.; Ruegg, C.

2022-05-19 cancer biology
10.1101/2022.04.03.485914 bioRxiv
Show abstract

Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) receptors, two clinically relevant targets for immunotherapy of cancer, are negative regulators of in immune cell activation and migration. However, optimizing therapeutic outcomes still requires fundamental research to reach a comprehensive insight into the coherent function of immune regulators. Here, we investigated the statistical dynamics of T cells migration as a measure of the functional response to these pathways in an experimental setup of immune checkpoint blockade. For this purpose, we used a previously developed 3-dimensional organotypic culture of patient-derived tumor spheroids. Experiment-based dynamical modeling remarked distinct characteristics of the receptors regulation followed through with the modification of their proportions in the immune modulation. We demonstrated that time-delayed kinetics of PD-1 activation just overrides its relatively more efficient cell-level function which potentially makes an operative contribution to the functional dominance of CTLA-4 in the tumor microenvironment. Simulation results showed good agreement with data for tumor cells reduction and active immune cells count observed in each experiment. These analyses propose a new mechanistic view on relative immunogenicity of PD-1 and CTLA-4 inhibitors manifested in literature and point the possible inherent obstacles in checkpoint inhibition-based immunotherapy of cancer to address in the future. SignificanceEx vivo monitoring of temporal response to PD-1 and CTLA-4 in the closure of T cell movement dynamics and elucidating their feasible commitment to the kinetic constraints at cell-level resolution. Delayed dynamics of migratory response to CTLA-4 inhibition revealed a mechanistic view on potential T cell reinvigoration following immune checkpoint blockade.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS Computational Biology
1633 papers in training set
Top 3%
12.0%
2
npj Systems Biology and Applications
99 papers in training set
Top 0.1%
8.9%
3
Scientific Reports
3102 papers in training set
Top 11%
8.2%
4
Cancer Immunology, Immunotherapy
11 papers in training set
Top 0.1%
6.1%
5
eLife
5422 papers in training set
Top 15%
6.1%
6
Cancer Immunology Research
34 papers in training set
Top 0.1%
3.8%
7
Cancers
200 papers in training set
Top 1%
3.8%
8
Frontiers in Immunology
586 papers in training set
Top 2%
3.5%
50% of probability mass above
9
International Journal of Molecular Sciences
453 papers in training set
Top 3%
3.2%
10
Computational and Structural Biotechnology Journal
216 papers in training set
Top 2%
3.0%
11
Computers in Biology and Medicine
120 papers in training set
Top 1%
2.3%
12
iScience
1063 papers in training set
Top 9%
2.3%
13
Cell Communication and Signaling
35 papers in training set
Top 0.3%
1.8%
14
Communications Biology
886 papers in training set
Top 8%
1.7%
15
PLOS ONE
4510 papers in training set
Top 53%
1.7%
16
APL Bioengineering
18 papers in training set
Top 0.1%
1.6%
17
PeerJ
261 papers in training set
Top 9%
1.4%
18
Cell Reports
1338 papers in training set
Top 26%
1.4%
19
Nature Communications
4913 papers in training set
Top 55%
1.3%
20
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.8%
1.2%
21
Cancer Research Communications
46 papers in training set
Top 0.8%
1.1%
22
Patterns
70 papers in training set
Top 2%
1.1%
23
Cancer Research
116 papers in training set
Top 3%
0.9%
24
Physical Biology
43 papers in training set
Top 2%
0.9%
25
Frontiers in Oncology
95 papers in training set
Top 3%
0.8%
26
Antibody Therapeutics
16 papers in training set
Top 0.5%
0.8%
27
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 9%
0.8%
28
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.3%
0.7%
29
ACS Pharmacology & Translational Science
40 papers in training set
Top 1%
0.7%
30
OncoImmunology
22 papers in training set
Top 0.5%
0.6%